These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 15305907

  • 1. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH, Gabrail NY, Conklin R, Hohneker JA, Berg WJ, Warsi G, Maloney J, Benedetto JJ, Miles EA, Zhu W, Anthony L.
    J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
    Hoff PM, Saragiotto DF, Barrios CH, del Giglio A, Coutinho AK, Andrade AC, Dutra C, Forones NM, Correa M, Portella Mdo S, Passos VQ, Chinen RN, van Eyll B.
    J Clin Oncol; 2014 Apr 01; 32(10):1006-11. PubMed ID: 24516038
    [Abstract] [Full Text] [Related]

  • 5. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
    Wasserman E, Hidalgo M, Hornedo J, Cortés-Funes H.
    Bone Marrow Transplant; 1997 Nov 01; 20(9):711-4. PubMed ID: 9384471
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
    Bhattacharya S, Vijayasekar C, Worlding J, Mathew G.
    Acta Gastroenterol Belg; 2009 Nov 01; 72(3):289-95. PubMed ID: 19902860
    [Abstract] [Full Text] [Related]

  • 10. Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery.
    Gullichsen R.
    Tech Coloproctol; 2006 Dec 01; 10(4):346-9. PubMed ID: 17115310
    [Abstract] [Full Text] [Related]

  • 11. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease.
    Pai V, Porter K, Ranalli M.
    Pediatr Blood Cancer; 2011 Jan 01; 56(1):45-9. PubMed ID: 21108438
    [Abstract] [Full Text] [Related]

  • 12. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V, Koumakis G, Vassilomanolakis M, Demiri M, Efremidis AP.
    Support Care Cancer; 2001 Jun 01; 9(4):258-60. PubMed ID: 11430421
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrhea.
    Pro B, Lozano R, Ajani JA.
    Invest New Drugs; 2001 Jun 01; 19(4):341-3. PubMed ID: 11561696
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy induced diarrhea.
    Richardson G, Dobish R.
    J Oncol Pharm Pract; 2007 Dec 01; 13(4):181-98. PubMed ID: 18045778
    [Abstract] [Full Text] [Related]

  • 15. [Management of chemotherapy induced diarrhea].
    Schultz M, Schölmerich J, Kullmann F.
    Z Gastroenterol; 2004 Jun 01; 42(6):527-38. PubMed ID: 15190449
    [Abstract] [Full Text] [Related]

  • 16. Octreotide Acetate in the Treatment of Fluorouracil-Induced Diarrhea.
    Goumas P, Naxakis S, Christopoulou A, Chrysanthopoulos C, Nikolopoulou V, Kalofonos HP.
    Oncologist; 1998 Jun 01; 3(1):50-53. PubMed ID: 10388084
    [Abstract] [Full Text] [Related]

  • 17. Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.
    Beaugerie L, Baumer P, Chaussade S, Berard H, Rozenbaum W, Pialoux G, Le Quintrec Y, Schwartz JC, Lecomte JM.
    Eur J Gastroenterol Hepatol; 1996 May 01; 8(5):485-9. PubMed ID: 8804878
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic review.
    Deng C, Deng B, Jia L, Tan H.
    BMJ Open; 2017 Jun 21; 7(6):e014916. PubMed ID: 28637728
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec 21; 14(80):230-3. PubMed ID: 16400749
    [Abstract] [Full Text] [Related]

  • 20. First-line chemotherapy with low-dose leucovorin plus 5-fluorouracil (LV/5-FU) for elderly patients with metastatic colorectal cancer.
    Yoshimatsu K, Yokomizo H, Fujimoto T, Umehara A, Otani T, Matsumoto A, Osawa G, Shiozawa S, Katsube T, Naritaka Y, Ogawa K.
    Anticancer Res; 2007 Dec 21; 27(3B):1641-4. PubMed ID: 17595789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.